ST. PAUL, Minn.--(BUSINESS WIRE)-- Today, CNS Therapeutics announced the FDA approval of Gablofen® (baclofen injection) for use in the management of severe spasticity, giving healthcare providers a ...
Researchers from Kessler Foundation and Kessler Institute for Rehabilitation (collectively "Kessler") conducted the first prospective study to assess whether transcutaneous spinal stimulation (TSS) ...
Mount Olive, New Jersey-based Flowonix Medical Inc. said Wednesday that the United States Food and Drug Administration granted approval to market the Prometra II Programmable Pump System for use with ...
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Today, Nexus Pharmaceuticals announced the launch of Baclofen Injection, USP. This sterile solution is designed for intrathecal administration and serves as a ...
Kessler pilot study shows pump delivery system unaffected although interference with communication may occur during the pump’s log transmission The pilot study was conducted at the Tim and Caroline ...
Three medications have spasticity reduction as their primary indication: baclofen (Lioresal ®), dantrolene (Dantrium ®), and tizanidine (Zanaflex ®). These drugs represent the mainstays of ...
A year-old boy underwent an uncomplicated placement of an intrathecal baclofen pump for the treatment of spasticity due to cerebral palsy. A CT dye study revealed a portion of the catheter directly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results